Grifols USA LLC
UnclaimedPharmaceutical Preparation ManufacturingLos Angeles, CA
Founded
1995
Primary NAICS
325412
CAGE code
1N5P5
Federal awards
$4.6M
Overview
Explore Grifols' comprehensive, innovative and patient-centric biopharma and healthcare solutions.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $377,947 | 15 |
| 2025 | Department of Veterans Affairs | $680,336 | 13 |
| 2025 | Department of Health and Human Services | -$161 | 3 |
| 2024 | Department of Veterans Affairs | $609,542 | 22 |
| 2024 | Department of Health and Human Services | $61,720 | 8 |
| 2024 | Department of Justice | -$247 | 1 |
| 2023 | Department of Health and Human Services | $1,022,964 | 14 |
| 2023 | Department of Veterans Affairs | $773,956 | 25 |
| 2023 | Department of Justice | $56,799 | 7 |
| 2022 | Department of Health and Human Services | $1,019,463 | 13 |
| 2022 | Department of Veterans Affairs | $0 | 6 |